Sec Form 4 Filing - CMEA VENTURES VI LP @ TETRAPHASE PHARMACEUTICALS INC - 2013-09-16

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
CMEA VENTURES VI LP
2. Issuer Name and Ticker or Trading Symbol
TETRAPHASE PHARMACEUTICALS INC [ TTPH]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
1 LETTERMAN DR., BLDG. C, SUITE CM500
3. Date of Earliest Transaction (MM/DD/YY)
09/16/2013
(Street)
SAN FRANCISCO, CA94129
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_____ Form filed by One Reporting Person
__ X __ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/16/2013 S 44,207 D $ 9.22 2,112,923 D ( 1 )
Common Stock 09/17/2013 S 8,012 D $ 9.48 2,104,911 D ( 1 )
Common Stock 09/16/2013 S 1,057 D $ 9.22 50,519 D ( 2 )
Common Stock 09/17/2013 S 192 D $ 9.48 50,327 D ( 2 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
CMEA VENTURES VI LP
1 LETTERMAN DR., BLDG. C, SUITE CM500
SAN FRANCISCO, CA94129
X
CMEA Ventures VI GmbH & Co. KG
1 LETTERMAN DR., BLDG. C, SUITE CM500
SAN FRANCISCO, CA94129
X
CMEA Ventures VI Management, L.P.
1 LETTERMAN DR., BLDG. C, SUITE CM500
SAN FRANCISCO, CA94129
X
BARUCH THOMAS R
1 LETTERMAN DR., BLDG. C, SUITE CM500
SAN FRANCISCO, CA94129
X
Collier David J
1 LETTERMAN DR., BLDG. C, SUITE CM500
SAN FRANCISCO, CA94129
X
Sohail Faysal A.
1 LETTERMAN DR., BLDG. C, SUITE CM500
SAN FRANCISCO, CA94129
X
Watson James F
1 LETTERMAN DR., BLDG. C, SUITE CM500
SAN FRANCISCO, CA94129
X
Signatures
/s/ James F. Watson - General Partner of CMEA Ventures VI Management, L.P., General Partner of CMEA Ventures VI, L.P. 09/18/2013
Signature of Reporting Person Date
/s/ James F. Watson - General Partner of CMEA Ventures VI Management, L.P., managing limited partner of CMEA Ventures VI Gmbh & Co. KG, L.P. 09/18/2013
Signature of Reporting Person Date
/s/ James F. Watson - General Partner of CMEA Ventures VI Management, L.P. 09/18/2013
Signature of Reporting Person Date
/s/ Thomas R. Baruch 09/18/2013
Signature of Reporting Person Date
/s/ David J. Collier 09/18/2013
Signature of Reporting Person Date
/s/ Faysal A. Sohail 09/18/2013
Signature of Reporting Person Date
/s/ James F. Watson 09/18/2013
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The shares are directly held by CMEA Ventures VI, L.P. ("CMEA VI"). The general partner of CMEA VI is CMEA Ventures VI Management, L.P. ("CMEA VI GP"). The general partners of CMEA VI GP are Thomas R. Baruch ("Baruch"), David J. Collier ("Collier"), Faysal A. Sohail ("Sohail"), and James F. Watson ("Watson") and, as such, each of these individuals exercises shared voting and investment power over the shares held of record by CMEA VI. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.
( 2 )The shares are directly held by CMEA Ventures VI GmbH & Co. KG ("CMEA VI GmbH"). The managing limited partner of CMEA VI GmbH is CMEA VI GP. The general partners of CMEA VI GP are Baruch, Collier, Sohail, and Watson and, as such, each of these individuals exercises shared voting and investment power over the shares held of record by CMEA VI GmbH. Each of the filing persons disclaims beneficial ownership of the shares except to the extent of their pecuniary interest therein, if any.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.